{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-072046","form_type":"8-K","ticker":"HLF","cik":"0001180262","company_name":"HERBALIFE LTD.","filed_at":"2024-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.580564+00:00","generated_at":"2026-06-04T11:20:26.505923+00:00","sec_items":["2.05","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Herbalife appoints John DeSimone as CFO; announces restructuring and 2024 guidance","bullets":["John DeSimone appointed CFO effective March 17, 2024; Alex Amezquita remains with company.","Board approved restructuring plan requiring at least $60M pre-tax expenses in 2024, primarily severance.","Q1 2024 guidance: net sales +1-3% y-o-y; adjusted EBITDA $115-130M.","FY 2024 guidance: net sales +0-5% y-o-y; adjusted EBITDA $540-580M; capex $125-175M.","Expects at least $80M annual run-rate savings from restructuring beginning in 2025; targets gross leverage ratio 3.0x by end 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-072046","json":"https://secwatch.observer/filing/0001193125-24-072046.json","markdown":"https://secwatch.observer/filing/0001193125-24-072046.md","text":"https://secwatch.observer/filing/0001193125-24-072046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1180262/000119312524072046/0001193125-24-072046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1180262/000119312524072046/d809540d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T11:20:26.505923+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c5ff92001","claim":"Alex Amezquita departed as Chief Financial Officer at HERBALIFE LTD..","evidence_excerpt":"On March 17, 2024, Alex Amezquita ceased to serve as the Company’s Chief Financial Officer but will continue to serve as an employee of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1180262/000119312524072046/0001193125-24-072046-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to serve"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"9e1a164fac","claim":"John DeSimone was appointed as Chief Financial Officer at HERBALIFE LTD..","evidence_excerpt":"On March 17, 2024, John DeSimone was appointed as the Company’s Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1180262/000119312524072046/0001193125-24-072046-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"7456a9ef621315d67879f28a5f2ded4e5f4c2769","claim":"HERBALIFE LTD. announced a restructuring with charges of at least $60 million of pre-tax expenses.","evidence_excerpt":"The Company expects to recognize at least $60 million of pre-tax expenses in 2024 related to the restructuring, which is primarily related to severance costs.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1180262/000119312524072046/0001193125-24-072046-index.htm","confidence":1.0,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"at least $60 million of pre-tax expenses"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}